FDA Inspection
Boehringer Ingelheim RCV GmbH & Co KGBoehringer Ingelheim RCV GmbH & Co KG – FDA Inspection, Jul 17, 2018
Record Details
This FDA Inspection record concerns Boehringer Ingelheim RCV GmbH & Co KG, with an inspection on July 17, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- Person
- Diane L. Raccasi (Issuing Officer)
View Company Profile
ID · 1f790bf0-6f1e-45b3-b074-efe3475835e7
Inspection Facts
- Inspection number
- 1069733
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Boehringer Ingelheim RCV GmbH & Co KG
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2024 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 5, 2023 | Not classified | Office of Inspections and Investigations | |
| November 16, 2023 | Not classified | Office of Inspections and Investigations | |
| March 2, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Boehringer Ingelheim RCV GmbH & Co KG
- FDA Inspection 1258048 - 2024-11-12
- FDA Inspection 1226783 - 2023-12-05
- FDA Inspection 1223893 - 2023-11-16
- FDA Inspection 1210971 - 2023-03-02
- FDA Inspection 1182096 - 2022-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.